Long-term results of alpha interferon as initial therapy and splenectomy as consolidation therapy in patients with hairy cell leukemia. Final report from the Italian Cooperative Group for HCL
Massimo Federico(University of Modena and Reggio Emilia), E Damasio(Istituto di Ematologia di Bologna), Teresa Lamparelli(Ospedale Policlinico San Martino), Giovanni Capnist(Ospedale San Bortolo), L Resegotti, Teodoro Chisesi(Ospedale Civile di Venezia), Antonio Frassoldati(Italian Oncology Group of Clinical Research), Luca Baldini(University of Milan), F. Lauria(Istituto di Ematologia di Bologna), Luciana Annino(Sapienza University of Rome), Rosangela Invernizzi(University of Pavia), Mauro Truini(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Paola Francia di Celle(Institute for Sustainable Plant Protection), R. Foà, V. Silingardi(Azienda Ospedaliero-Universitaria di Modena), Maura Brugiatelli(Azienda Ospedaliera Ospedali Riuniti Papardo Piemonte)
Cited by 22
Related Papers
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study.
|PubMed|2006|909
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
|The Lancet|2018|733